Physician profile
Cherry Song
NPI 1043445075
$926.93
in general payments reported to CMS, 2019-2025
9 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $49.48 · 2024: $219 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $181.82 | 2025 | Matriderm |
| Acera Surgical, INC. | $171.82 | 2024-2025 | Restrata Wound Matrix |
| Avita Medical Americas, LLC | $153.07 | 2023-2025 | Recell, Permeaderm, Cohealyx |
| Kerecis Limited | $118.88 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Urgo Medical North America, LLC | $70.92 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Vericel Corporation | $68.51 | 2025 | Nexobrid |
| Polynovo North America LLC | $60.74 | 2024-2025 | Novosorb Btm |
| Baxter Healthcare | $55.52 | 2025 | Artiss |
| Smith+Nephew, INC. | $45.65 | 2025 | "Acticoat 4"" X 4""", Collagenase Santyl, Oasis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherry Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.